Your session is about to expire
← Back to Search
Hormone Therapy
hypoxia measurement for Prostate Cancer
N/A
Waitlist Available
Led By Michael Milosevic, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
Study Summary
This trial is testing whether the hormone therapy Casodex can improve oxygen levels in the prostate, which may help treat the cancer.
Eligible Conditions
- Prostate Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Correlate level of tumor oxygenation with PSA level
Correlate level of tumor oxygenation with hemoglobin level
Correlate level of tumor oxygenation with prostate volume
+1 moreSecondary outcome measures
To study of the effect of neoadjuvant anti-androgen therapy on prostate tumour histopathology and gene expression, and correlation of these effects with changes in oxygenation.
Trial Design
1Treatment groups
Experimental Treatment
Group I: hypoxia measurementExperimental Treatment1 Intervention
Patients undergoing or planning to receive combined anti-androgen (Casodex) and radiotherapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
hypoxia measurement
2001
N/A
~30
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,468 Previous Clinical Trials
484,489 Total Patients Enrolled
64 Trials studying Prostate Cancer
15,400 Patients Enrolled for Prostate Cancer
Princess Margaret Hospital, CanadaOTHER
119 Previous Clinical Trials
39,029 Total Patients Enrolled
10 Trials studying Prostate Cancer
9,916 Patients Enrolled for Prostate Cancer
Canadian Cancer Trials GroupNETWORK
124 Previous Clinical Trials
67,423 Total Patients Enrolled
11 Trials studying Prostate Cancer
7,135 Patients Enrolled for Prostate Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: hypoxia measurement
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any open slots remaining in this clinical research?
"According to clinicaltrials.gov, this trial has ceased recruiting patients and was last updated on October 20th 2022. Although no longer enrolling subjects, the website claims that there are 1,409 other trials presently accepting participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger